Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And CompanyfiledCriticalEli Lilly And Company
Priority to YU73891ApriorityCriticalpatent/YU73891A/en
Publication of YU73891ApublicationCriticalpatent/YU73891A/en
Preparation Of Compounds By Using Micro-Organisms
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Peptides Or Proteins
(AREA)
Abstract
ANALOZI FAKTORA KOJI OSLOBADJAJU HORMON RASTA, opisani su novi analozi faktora koji oslobadjaju hormon rasta (GRF) kao i hemijski modifikovane verzije tih molekula i predstavljaju DNK jedinjenja koja šifruju GRF analoge; neka od polipeptidnih jedinjenja se mogu dobiti u većim prinosima produkcijom jedinjenja u E. coli; kao i farmaceutske kompozicije i metode za pobudjivanje oslobadjanja hormona rasta.ANALYSIS OF GROWTH-RELEASING FACTORS, new growth hormone-releasing factor (GRF) analogs are described as well as chemically modified versions of these molecules and represent DNA compounds that encode GRF analogs; some of the polypeptide compounds can be obtained in higher yields by producing the compounds in E. coli; as well as pharmaceutical compositions and methods for inducing the release of growth hormone.
YU73891A1991-04-231991-04-23
ANALOGS OF FACTORS RELEASING GROWTH HORMONE
YU73891A
(en)
Humanized antibodies, methods for producing thereof, a method for treatment of Crohns disease, a method for treatment OF disseminated sclerosis, pharmaceutical composition
Compound, use of a growth hormone secretagogue or a pharmaceutically acceptable salt thereof, pharmaceutical composition, method to stimulate the release of growth hormone by a mammal's pituitary, and use of a compound